CHINA TOPIX

11/22/2024 01:48:48 pm

Make CT Your Homepage

Sofosbuvir

Hepatitis C

Survey Shows Hepatitis C Patients Lack Access to Treatment

A recent survey in mainland China has revealed that a majority of the patients suffering from hepatitis C in the country do not use the standard treatment because of side effects and its expensive costs.

Truvada pills

U.S. Approves Expensive New Pill for Hepatitis C

Regulators in the United States approved on Friday Harvoni, a pill to be taken every day to treat hepatitis C that is easier to take but is pricier compared to the existing treatments.

Real Time Analytics